Market research

Gadolinium-157

Explore licenses

360iResearch introduction

Gadolinium-157: Strategic Context and Scope

Gadolinium-157 is a stable isotope of gadolinium with relevance to neutron physics, radiation detection, shielding research, and specialized scientific applications because gadolinium has a high neutron-capture cross section. Its role should be assessed separately from broader gadolinium compounds and from radioactive gadolinium isotopes. Demand conditions depend on isotope enrichment, analytical-grade specifications, handling requirements, research infrastructure, and applicable nuclear-material controls.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Form

    • Nanoparticle Form
    • Powder Form
    • Rod Form
    • Solution Form
    View chapter
  2. Chapter 8 Grade

    • High Purity
    • Research Grade
    • Technical Grade
    • Ultra High Purity
    View chapter
  3. Chapter 9 Application

    • Industrial Radiography
    • MRI Contrast Agent
    • Neutron Capture Therapy
    • Nuclear Reactor Control
    More in this chapter

Scientific and Supply-Chain Shifts Shaping Gadolinium-157

The landscape is being shaped by tighter expectations for isotopic purity, traceability, reproducibility, and secure transport. Progress in neutron instrumentation, detector development, isotope production, and materials characterization is increasing the importance of validated specifications rather than simple elemental availability. Supply chains remain specialized because separation, conversion, quality assurance, and regulated logistics require technical capabilities that are not broadly interchangeable.

How Artificial Intelligence Is Affecting Gadolinium-157 Applications

Artificial intelligence can influence this field through neutron-transport modeling, detector-response optimization, materials discovery, anomaly detection in analytical data, and predictive maintenance of research equipment. Its practical value depends on high-quality experimental datasets, transparent validation, and safeguards against model error in radiation-related decisions. AI is therefore best treated as an enabling layer for research and process control, not as a substitute for isotope metrology, laboratory testing, or regulatory review.

Regional Insights Across the Gadolinium-157 Ecosystem

North America combines advanced nuclear research, detector development, and regulated isotope handling capabilities. Europe benefits from strong scientific collaboration and established nuclear and analytical infrastructure. Asia-Pacific includes major research, manufacturing, and technology centers, with activity linked to neutron science and advanced materials. Latin America is supported by selected research and medical-technology institutions but faces more uneven access to specialized isotope infrastructure. The Middle East is developing scientific and nuclear capabilities with emphasis on controlled applications, while Africa’s activity is concentrated in research institutions and nuclear-science programs, making partnerships and secure logistics particularly important.

How ASEAN, BRICS, EU, G7, GCC, and NATO Shape Demand

ASEAN’s relevance reflects expanding research and technology capacity across member economies, although specialized isotope access can vary considerably. BRICS provides a broad platform for nuclear science, materials research, and technical cooperation across diverse national systems. The European Union supports cross-border research, common safety expectations, and coordinated scientific infrastructure. G7 members contribute substantial capabilities in advanced instrumentation, isotope science, and regulatory practice. GCC states are strengthening scientific and nuclear institutions, while NATO countries influence demand through defense-adjacent sensing, radiation protection, and secure technology programs, subject to national controls and alliance rules.

Country-Level Signals: Australia to the United States

Australia has established nuclear-science and research capabilities relevant to neutron applications. Brazil and Mexico support regional research and nuclear institutions, while Canada and the United States maintain sophisticated facilities for isotope science, neutron research, and radiation measurement. China, Japan, South Korea, and India combine significant industrial or scientific capacity with active advanced-materials and nuclear research programs. France, Germany, Italy, Spain, and the United Kingdom benefit from mature research ecosystems and regulated laboratory infrastructure. Russia retains deep nuclear-science expertise, although access, cooperation, and logistics may be affected by regulatory and geopolitical constraints. Across all countries, the most important differentiators are verified isotopic purity, dependable documentation, institutional capability, and compliance with transport and nuclear-material requirements.

Practical Priorities for Industry and Research Leaders

Leaders should qualify suppliers against isotope identity, enrichment or purity documentation, contamination limits, chain of custody, and batch-level analytical evidence. They should maintain dual-source or contingency plans where permitted, map licensing and transport obligations before procurement, and align material specifications with the intended neutron or analytical use. Collaboration with accredited laboratories and specialized research institutions can reduce technical risk. Organizations adopting AI should establish governed datasets, independent validation, human oversight, and audit trails. Scenario planning should also address export controls, facility interruptions, packaging requirements, and changes in research funding.

Methodology for a Responsible Gadolinium-157 Assessment

A sound assessment distinguishes Gadolinium-157 from natural gadolinium, other isotopes, compounds, and unrelated radiological materials. It triangulates peer-reviewed isotope and neutron-science literature, official nuclear and radiation-safety guidance, laboratory and facility documentation, customs or trade records where classification is sufficiently clear, and publicly documented research programs. Qualitative comparisons should be based on observable capabilities such as enrichment technology, analytical infrastructure, regulatory maturity, research activity, and logistics readiness. Because specialized isotope data can be sparse or confidential, conclusions should identify uncertainty and avoid inferring precise demand, supply, or commercial scale without independently verifiable evidence.

Conclusion: Building Resilient Capability Around Gadolinium-157

Gadolinium-157 occupies a specialized position at the intersection of isotope science, neutron technology, materials research, and regulated logistics. The strongest long-term opportunities are linked to reliable characterization, advanced instrumentation, secure supply practices, and collaborative scientific infrastructure. Organizations that combine rigorous metrology with regulatory discipline and carefully validated digital tools will be better positioned to use the isotope responsibly. Regional and national differences remain significant, so procurement and research strategies should be tailored to local capabilities, controls, and access conditions.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Gadolinium-157 Market, by Form
    1. 7.1Introduction
    2. 7.2Nanoparticle Form
    3. 7.3Powder Form
    4. 7.4Rod Form
    5. 7.5Solution Form
  8. 8.Gadolinium-157 Market, by Grade
    1. 8.1Introduction
    2. 8.2High Purity
    3. 8.3Research Grade
    4. 8.4Technical Grade
    5. 8.5Ultra High Purity
  9. 9.Gadolinium-157 Market, by Application
    1. 9.1Introduction
    2. 9.2Industrial Radiography
      1. 9.2.1Gamma Imaging
      2. 9.2.2X-Ray Imaging
    3. 9.3MRI Contrast Agent
      1. 9.3.1T1 Agents
      2. 9.3.2T2 Agents
    4. 9.4Neutron Capture Therapy
      1. 9.4.1Epithermal Neutron
      2. 9.4.2Thermal Neutron
    5. 9.5Nuclear Reactor Control
      1. 9.5.1Burnable Absorbers
      2. 9.5.2Control Rods
    6. 9.6Radiation Shielding
      1. 9.6.1Gamma Shielding
      2. 9.6.2Neutron Shielding
  10. 10.Gadolinium-157 Market, by End User
    1. 10.1Introduction
    2. 10.2Hospitals And Diagnostic Centers
    3. 10.3Industrial Laboratories
    4. 10.4Nuclear Power Plants
    5. 10.5Pharmaceutical Companies
    6. 10.6Research Institutes
  11. 11.Gadolinium-157 Market, by Region
    1. 11.1Introduction
    2. 11.2Asia-Pacific
    3. 11.3North America
    4. 11.4Latin America
    5. 11.5Europe
    6. 11.6Middle East
    7. 11.7Africa
  12. 12.Gadolinium-157 Market, by Group
    1. 12.1Introduction
    2. 12.2ASEAN
    3. 12.3GCC
    4. 12.4European Union
    5. 12.5BRICS
    6. 12.6G7
    7. 12.7NATO
  13. 13.Gadolinium-157 Market, by Country
    1. 13.1Introduction
    2. 13.2United States
    3. 13.3Canada
    4. 13.4Mexico
    5. 13.5Brazil
    6. 13.6United Kingdom
    7. 13.7Germany
    8. 13.8France
    9. 13.9Russia
    10. 13.10Italy
    11. 13.11Spain
    12. 13.12China
    13. 13.13India
    14. 13.14Japan
    15. 13.15Australia
    16. 13.16South Korea
  14. 14.Competitive Landscape
    1. 14.1Market Share Analysis, 2025
    2. 14.2Market Concentration Analysis, 2025
      1. 14.2.1Concentration Ratio (CR)
      2. 14.2.2Herfindahl Hirschman Index (HHI)
    3. 14.3Recent Developments & Impact Analysis, 2025
    4. 14.4Product Portfolio Analysis, 2025
    5. 14.5Benchmarking Analysis, 2025
  15. 15.Company Profiles
    1. 15.1American Elements Corporation
    2. 15.2ASP Isotopes Inc.
    3. 15.3Cambridge Isotope Laboratories, Inc.
    4. 15.4Eurisotop SAS
    5. 15.5GFS Chemicals, Inc.
    6. 15.6Isoflex USA, Inc.
    7. 15.7Isotope Technologies Munich SE
    8. 15.8Kinectrics Inc.
    9. 15.9LGC Limited
    10. 15.10Merck KGaA
    11. 15.11Nordion (Canada) Inc.
    12. 15.12Nusano, Inc.
    13. 15.13Rare Earth Products, Inc.
    14. 15.14Trace Sciences International, LLC
  16. 16.Key Experts

Loading the sample request form…